Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 147 posts found.

8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017
Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

News
brainss

Axovant shares capitulate after Alzheimer’s drug failure

September 26, 2017
Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

News
alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Feature
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017
Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

News
brainss

Enzyme able to untangle protein aggregates associated with Alzheimer’s

June 29, 2017
Research and Development Alzheimer's, Parkinson's

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …

News
shutterstock_311949818

Immune system attacks the brain in Alzheimer’s, study suggests

June 22, 2017
Research and Development Alzheimer's

New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …

News
cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017
Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

News
800px-lab_mouse_mg_3154

New drug study successfully halts neurodegeneration in mice

April 20, 2017
Research and Development Alzheimer's, Parkinson's, trazodone

A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified methods to prevent neurodegeneration …

News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017
Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017
Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …

News

Two Phase 3 failures put nail in the coffin for Lundbeck Alzheimer’s drug

February 9, 2017
Research and Development, Sales and Marketing Alzheimer's, Lundbeck, idalopirdine

Danish pharma firm Lundbeck has announced the failure of two Phase 3 trials investigating its experimental Alzheimer’s treatment idalopirdine; the …

News
alzheimers_brain

Scientists identify key role of divisive Alzheimer’s protein

February 8, 2017
Research and Development Alzheimer's

Researchers from the Stark Neurosciences Research Institute at Indiana University have claimed to have finally identified the purpose of an …

News
researchers_credit_neusentis_pfizer

Benzodiazepines increase stroke risk in Alzheimer’s patients, study finds

January 16, 2017
Research and Development, Sales and Marketing Alzheimer's, Alzheimers, benzodiazepines

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …

News
shutterstock_311949818

First human trial of tau-targeting Alzheimer’s vaccine shows promise

December 15, 2016
Medical Communications, Research and Development Alzheimer's

The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …

News
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016
Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023